CClinicalTrials.gg
CompletedNCT02058862Updated Oct 9, 2018

Effect of a Home-based Electrical Stimulation on Quadriceps Function After Knee Surgery

An observational study in Post-operative Quadriceps Weakness, Post-operative Quadriceps Inhibition and Adherence to Post-operative Treatment, sponsored by University of Kentucky. Completed at 2 sites in United States. Open to participants aged 12 Years to 60 Years. Per ClinicalTrials.gov, last updated 2018-10-09.

Sponsored by University of Kentucky · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
87
Ages
12 Years to 60 Years
Sex
All
01

Study summary

The purpose of this study is to determine if a home-based electrical stimulation (ES) program is more effective than the standard of care (SOC) at improving quadriceps function, functional outcomes, patient reported outcomes, and treatment compliance in patients recovering from knee surgery. It is hypothesized that there will be significantly better outcomes and compliance in ES group when compared to the SOC group.

Read the detailed description

The purpose of this study is to evaluate the effect of home-based neuromuscular electrical stimulation applied via a knee sleeve on strength, function, inhibition, and patient reported outcomes. Strength will be evaluated via isometric knee extension, neuromuscular inhibition will be assessed via a superimposed burst technique, and cortical excitability will be assessed via transcranial magnetic stimulation. In addition, we will evaluate function through a single-leg hop task, star excursion balance test, and a step down task. Patient reported outcomes will be assessed via the: Veterans Rand 12 Item Health Survey (VR-12), Knee Osteoarthritis Outcomes Score (KOOS), the International Cartilage Repair Society (ICRS), the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, and the Lysholm scale.

Once a participant is identified as eligible and consents to enroll in the study, they will be allocated to either an intervention or control group. The participants in the intervention group will receive a knee sleeve that has a neuromuscular ES unit embedded into the garment (EMPI Phoenix, DJO Global, Vista, California) in addition to SOC. A superimposed electrical signal (maximal toleration) will be utilized during treatment in order to successfully overload the muscle. During the electrical stimulation the participants will be instructed to perform an isometric contraction and hold this contraction through the length of the stimulation. Beginning one week post-operatively the participants will be instructed to perform NMES treatment 3 times a day for 20 minutes 5 times a week for 12 weeks. The stimulation will be delivered at a frequency of 75Hz with a duty cycle of 4 seconds on and 10 seconds off. The control group will be treated with the current SOC, performing a home-based treatment of volitional isometrics contractions without the addition of neuromuscular electrical stimulation beginning on the third day post-operatively. Participants will perform 20 isometric contractions holding each contraction for 10 seconds 3 times a day 5 times a week for 12 weeks. Participants will be instructed to keep a treatment log documenting at each session how many exercises and at what intensity they performed.

02

Conditions studied

  • Post-operative Quadriceps Weakness
  • Post-operative Quadriceps Inhibition
  • Adherence to Post-operative Treatment
  • Post-operative Lower Extremity Function
03

In context

Lead sponsor

University of Kentucky is the lead sponsor of 68 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients from the University of Kentucky Orthopaedics and Sports Medicine Clinic who are seeking surgical treatment for a disease/injury of the knee.

Inclusion criteria

  • Must be scheduled for surgery to address pain, injury, or dysfunction of the knee joint.
  • Must be able to communicate using the English language

Exclusion criteria

Exclusion Criteria:

  • Previous surgery to the contralateral ankle, hip, or knee
  • Injury to the hip, ankle, or contralateral knee in the past six months
  • Currently being treated for low back pain
  • Presence of a heart condition/pacemaker
  • History and/or family history of seizures/epilepsy
  • Vestibular or other balance disorders
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
87 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Isometric knee extension torque

    Knee extension torque derived from a maximal voluntary isometric contraction

    Time frame: Preoperative baseline, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative

  2. Quadriceps activation

    Central activation ratio of the quadriceps derived from the superimposed burst technique

    Time frame: Preoperative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative

Secondary outcomes

  1. Patient-reported outcomes

    Patient-reported outcome measures will include the following: Veterans Rand 12 Item Health Survey (VR-12), Knee Osteoarthritis Outcomes Score (KOOS), the International Cartilage Repair Society (ICRS), the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, and the Lysholm scale

    Time frame: Preoperative, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative

  2. Functional outcomes

    Functional outcome measures will include the following: Single-leg hop, 30-second step down, and star-excursion balance test.

    Time frame: Preoperative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative

  3. Cortical excitability

    Individuals who have been diagnosed with epilepsy or have a family history of epilepsy may be at risk of seizure during cortical excitability testing. Therefore, these individuals will be excluded from this study. Otherwise, this measure is considered to be safe and is used in the realms of both medicine and research.

    Time frame: Preoperative, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative

Other outcomes

  1. Treatment compliance

    The number and duration of treatments performed by the patients

    Time frame: Preoperative, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative

07

Study locations

2 sites
  • University of Kentucky Musculoskeletal Laboratory
    Lexington, Kentucky 40506, United States
  • University of Kentucky Orthopaedics and Sports Medicine Clinic
    Lexington, Kentucky 40517, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 9, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02058862
Lead sponsor
University of Kentucky
Collaborators
DonJoy Orthopedics
Responsible party
Caitin Conley (PhD, ATC, University of Kentucky) — Principal investigator
First posted
Feb 10, 2014
Start date
May 2014
Primary completion
May 2017
Completion
Oct 2018
Last update
Oct 9, 2018

Study contacts

Conrad M Gabler, PhD, ATC
principal investigator · University of Kentucky
Caitlin E Whale Conley, PhD, ATC
principal investigator · University of Kentucky
Carl G Mattacola, PhD, ATC
study chair · University of Kentucky

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion